Literature DB >> 6389773

An enzyme-linked immunosorbent assay (ELISA) for IgG and IgA antibodies to respiratory syncytial virus in low dilutions of secretions of human serum and secretions.

N Nandapalan, E Routledge, G L Toms.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for titration of IgG and IgA antibodies to respiratory syncytial (RS) virus in low dilutions of human serum, colostrum, and nasopharyngeal secretions. Previously the sensitivity of RS virus ELISA on such specimens has been limited by nonspecific absorption of antibody, particularly IgA, to crude antigen preparations. For IgG antibody estimation in infant sera, this unwanted binding was reduced to workable levels by increasing the serum, salt, and detergent concentration of the diluent. Residual nonspecific binding of IgA in colostra appeared mainly due to antigen lipids or to lipoproteins. This was markedly reduced by partitioning Triton X-100-treated infected cell lysate antigens in Arklone. Using the modified ELISA technique for anti-RS virus IgA, good correlations were found with unfixed cell membrane immunofluorescence (MIF) for colostra (r = 0.81, P less than 0.001) and nasal secretions from adult volunteers. In several samples nonspecific absorption of antibody precluded MIF assay, but did not affect the ELISA. Although there was an overall correlation between ELISA for anti-RS IgG antibody in sera, the complement fixation test (r = 0.75, P less than 0.001), and MIF test (r = 0.82, P less than 0.001), the sensitivity of ELISA for antibody responses in convalescent sera of infants from 3 months to 2 years was poor. Conversely, the sensitivity of ELISA for antibody in the sera of older children and for transplacentally acquired antibody in very young infants was higher than that for the other two tests. ELISA was thus less reliable than either CF or MIF for detecting antibody rises in paired infant sera, particularly where maternally acquired antibody remained in the acute serum. The reasons for this apparent disparity are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389773     DOI: 10.1002/jmv.1890140313

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  The susceptibility of breast-fed and cow's milk formula-fed infant guinea pigs to upper respiratory tract infection with influenza virus.

Authors:  H M Ali; R Scott; G L Toms
Journal:  Br J Exp Pathol       Date:  1988-08

2.  Undetectable IgE responses after respiratory syncytial virus infection.

Authors:  G L Toms; R Quinn; J W Robinson
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

3.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

4.  IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.

Authors:  G L Toms; M S Webb; P D Milner; A D Milner; E G Routledge; R Scott; G M Stokes; A Swarbrick; C E Taylor
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

5.  Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus.

Authors:  L Vaur; H Agut; A Garbarg-Chenon; G Prud'Homme de Saint-Maur; J C Nicolas; F Bricout
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

6.  Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

Authors:  B R Murphy; B S Graham; G A Prince; E E Walsh; R M Chanock; D T Karzon; P F Wright
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

7.  Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.

Authors:  Natalie I Mazur; Nicole M Horsley; Janet A Englund; Maaike Nederend; Amalia Magaret; Azad Kumar; Shamir R Jacobino; Cornelis A M de Haan; Subarna K Khatry; Steven C LeClerq; Mark C Steinhoff; James M Tielsch; Joanne Katz; Barney S Graham; Louis J Bont; Jeanette H W Leusen; Helen Y Chu
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.